FDA digital advisers confront risks of therapy chatbots, weigh possible regulation
Because the technologies can pose novel risks , generative AI developers have expressed confusion about which use cases require regulation and what ...
Read the original at STAT News ↗
- Topics
- Regulation & PolicyChatbots & LLMsHealthcare
- Mentions
- FDA
- Tracked via
- “AI Risks”